|
FSD Pharma, Inc. (NASDAQ: HUGE) is our 2024 NASDAQ pick of the year and with the ex-dividend of a stock dividend coming up on Monday now is the time to own shares of an undervalued company poised to have major gains ahead.
|
|
Read more...
|
|
HUMBL, Inc. (OTC - HMBL), the only publicly traded pure play Web3 technology platform company, is poised for major gains ahead, led by revenue from its current clientele and a series of development and marketing milestones.
|
|
Read more...
|
|
Regen BioPharma, Inc. (OTC: RGBP) got surprising results from a set of recent in vitro experiments conducted by a CRO. Could this be a game-changing event in the autoimmune space for a company with deep IP in cancer and a series of IND submissions?
|
|
Read more...
|
|
Emerging AI-Driven Biotech Sybleu, Inc. (OTC:SYBE) offers competitive advantages and upcoming milestones in the stock market's top-followed and funded segment, AI, prompting a potential surge in the stock price.
|
|
Read more...
|
|
Interactive Strength, Inc. (NASDAQ: TRNR) d/b/a FORME is about to make a profound change in its business that will prompt major growth, accelerate profit, and drive the artificially low valuation substantially higher.
|
|
Read more...
|
|
Leveraging a $150M M&A-targeted credit facility, and a core relationship with Deepak Chopra, integrated health firm The Healing Company, Inc. (OTCQB: HLCO) is poised to record exponential revenue growth.
|
|
Read more...
|
|
Fresh off a successful IPO, NeurAxis Inc. (NYSE Amer: NRXS) is in the role of first mover with an FDA-cleared product in a huge market opportunity.
|
|
Read more...
|
|
New is a good thing. Sadot Group, Inc. (NASDAQ: SDOT) is the new name and symbol for Muscle Maker, Inc. (NASDAQ: GRIL) and its new initiatives will drive revenue and income growth.
|
|
Read more...
|
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
|
Page 1 of 39 |
